| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/02/2008 | US20080242671 Selective in presence of at least one other cathepsin isozyme; such as N-{-2-[2-(4-methoxy-phenylamino)-ethylcarbamoyl]-cyclohexyl}-3-methyl-benzamide |
| 10/02/2008 | US20080242670 Anti-Inflammatory Agents |
| 10/02/2008 | US20080242669 compounds which mimic the secondary structure of alpha -helix regions of biologically active peptides and proteins; compounds are used to reverse fibrotic conditions |
| 10/02/2008 | US20080242668 Neurodegenerative, inflammatory disorders, pain, drug abuse; useful as diagnostic tools or monitoring agents such as for neuroimaging, labelling; nicotinic and/or monoamine receptors modulators; 2,2'-Bis-((+-)-1-aza-bicyclo[2.2.2]oct-3-yloxy)-[5,5']-bithiazolyl; cholinergic ligands |
| 10/02/2008 | US20080242667 e.g. N-(4-{4-[2-({3-[2-(4-Morpholinyl)ethyl]phenyl}amino)-4-pyrimidinyl]-1H-pyrazol-3-yl}phenyl)benzamide; serine/threonine kinase inhibitor; anticarcinogenic, antitumor agent |
| 10/02/2008 | US20080242666 e.g. (3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-6-(1-ethylpropyl)-1-[2(hydroxymethyl)benzyl]-piperazine-2,5-dione; preparation by cyclization |
| 10/02/2008 | US20080242665 1-(4-((2-(2-aminopyrimidin-5-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazin-1-yl)-2-(methylsulfonyl)ethanone; lipid kinase inhibitor; anticarcinogenic agent; |
| 10/02/2008 | US20080242664 Dna-pk inhibitors |
| 10/02/2008 | US20080242663 [3-[[2-[(3,5-dimorpholin-4-ylphenyl)amino]pyrimidin-4-yl]-methyl-amino]-4-methyl-phenyl]methanol; protein tyrosine kinase EphB4 inhibitor; inhibit DNA synthesis; antiproliferative, antitumor agent |
| 10/02/2008 | US20080242662 substituted 3,4- or higher substituted piperazine compounds; renin inhibitor; antidiabetic, analgesic,hypotensive agent; neurodegenerative diseases; preparation by reacting a carbonic acid with amino compound |
| 10/02/2008 | US20080242661 Novel compounds useful for the treatment of degenerative & inflammatory diseases |
| 10/02/2008 | US20080242660 1,4-diazepin-1-sulfonyl-isoquinoline derivatives; Rho kinase, myosin light chain kinase or protein kinase C inhibitor; relaxing effect on vascular smooth muscles; hypotensive and vasodilating agent; occlusion or stenosis of an artery |
| 10/02/2008 | US20080242659 Compositions and methods for reducing cardiovascular morbidity and/or mortality |
| 10/02/2008 | US20080242658 Inhibitors of Iap |
| 10/02/2008 | US20080242657 Mixture with neuroleptic agent; reducing tremors from Parkinson's disease, multiple sclerosis, strokes, dystonia |
| 10/02/2008 | US20080242656 N-Substituted-N-Sulfonylaminocyclopropane Compounds and Pharmaceutical Use Thereof |
| 10/02/2008 | US20080242655 Aza-indolyl compounds and methods of use |
| 10/02/2008 | US20080242654 Novel compounds as cannabinoid receptor ligands |
| 10/02/2008 | US20080242653 Cyclopropyl amine derivatives |
| 10/02/2008 | US20080242652 Indole derivatives and their metal conjugates and uses thereof |
| 10/02/2008 | US20080242651 3-(2-cyclopentyl-2-phenyl-2-hydroxyacetoxy)-1-(carboxymethyl)-1-methylpyrrolidinium inner salt; muscarinic receptor antagonist; chronic obstructive pulmonary disease or asthma; synergistic mixture with antiinflammatory corticosteroid, betamimetic agent or antiallergic agent |
| 10/02/2008 | US20080242650 Oral contraceptive regimen |
| 10/02/2008 | US20080242649 Mixture of -(2-(diethylamino)ethyl)-N-(2-(4-hydroxy-2-oxo-2,3-dihydro-1,3-benzothiazol-7-yl)ethylmino)ethyl)-3-(2-(1-naphthyl)ethoxypropanamide and glucocorticoid receptor antagonist ; respiratory system disorders |
| 10/02/2008 | US20080242648 COMBINATION OF ERa+ LIGANDS AND HISTONE DEACETYLASE INHIBITORS FOR THE TREATMENT OF CANCER |
| 10/02/2008 | US20080242646 Split dose corticosteroid therapy |
| 10/02/2008 | US20080242645 Mixture of xanthine compound, plant extract containing polyurethane powder and dimethicone; softness; reduced tackiness |
| 10/02/2008 | US20080242644 Therapy, prevention of thromboembolic disease, cancer and rheumatic diseases |
| 10/02/2008 | US20080242643 4-[({[4,5-bis(nitrooxy)pentyl]oxy}carbonyl)oxy]-3-[4-(methylsulfonyl)phenyl]-2-phenylbut-2-enoic acid; antiinflammatory, analgesic agent; rheumatic diseases, influenza, common cold, pain, dysmenorrhea, headache, neuralgia, synovitis, arthritis, osteoarthritis, cardiovascular disorders, anticoagulants |
| 10/02/2008 | US20080242642 Minocycline oral dosage forms for the treatment of acne |
| 10/02/2008 | US20080242641 Controlled release carrier selected from hydroxypropyl methyl cellulose, hydroxypropyl cellulose, and polyvinylpyrrolidone; improved pharmacokinetics as compared to immediate-release minocycline hydrochloride; side effect reduction |
| 10/02/2008 | US20080242640 Antiinflammatory agents; prevent infections |
| 10/02/2008 | US20080242639 Phosphagen Synthesis |
| 10/02/2008 | US20080242638 Induction of differential stress resistance and uses thereof |
| 10/02/2008 | US20080242637 Binding efficiency;cyxicity; therapy for lung, colon, ovariers tumor |
| 10/02/2008 | US20080242636 Modified cyclodextrin sulfate-71 (terigyn) as a microbicide agent |
| 10/02/2008 | US20080242635 Method for Lengthening the Seasonal Mobility Period of Fish |
| 10/02/2008 | US20080242634 Treatment for neuropathic pain due to spinal cord injury |
| 10/02/2008 | US20080242633 Methods of modulating apoptosis and platelet production using variants of cytochrome c |
| 10/02/2008 | US20080242632 Targets two or more Dna sequence ; anticancer agents, therapy for infections, antiinflammatory agents, autoimmune diseases; respiratory system disorders; liver disorders |
| 10/02/2008 | US20080242631 Impaired wound healing compositions and treatments |
| 10/02/2008 | US20080242630 Fusion proteins of mycobacterium tuberculosis |
| 10/02/2008 | US20080242629 Hybrid nucleic acids; controlling gene expression; metabolism disorders, obesity, diabetes |
| 10/02/2008 | US20080242628 In vivo |
| 10/02/2008 | US20080242627 Suppression gene expression |
| 10/02/2008 | US20080242626 End-Modified Poly(beta-amino esters) and Uses Thereof |
| 10/02/2008 | US20080242625 Nucleotide-Cochleate Compositions And Methods Of Use |
| 10/02/2008 | US20080242624 Cyclin D Polynucleotides, Polypeptides and Uses Thereof |
| 10/02/2008 | US20080242623 Microutrophin and Uses Thereof |
| 10/02/2008 | US20080242622 Calibrating drug resistance; using library of Rna interference; prevention gene expression of target mammal genes |
| 10/02/2008 | US20080242610 Anticarcinogenic agents; polypeptide including ligand that stimulants natural killer receptor and intracytoplasmic death domain |
| 10/02/2008 | US20080242609 Composition for the therapy of diabetes mellitus and adiposity |
| 10/02/2008 | US20080242608 Prevent apoptosis; reduce concentration of isomerase;Alzheimer's disease, Parkinson's disease, Huntington's disease; brain disorders , strokes, multiple sclerosis, antiischemic agents |
| 10/02/2008 | US20080242604 Nucleotide sequence coding protein; for therapy of periodontal disease; wound healing agent |
| 10/02/2008 | US20080242602 Methods and Compositions For the Inhibition of Hiv-1 Replication |
| 10/02/2008 | US20080242599 Compositions and Methods for Increasing Osteoblast Cell Differentiation and Bone Generation |
| 10/02/2008 | US20080242596 Such as 2-(2-(allyloxymethyl)-4-chloro-5-(4-ethylbenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; sodium dependent glucose cotransporter inhibitors; type 1 or type 2 diabetes and related disorders; combination formulations |
| 10/02/2008 | US20080242592 Administering dried plum solids with flavonoids, hydroxycinnamic acid, and a fiber component of soluble fiber, and a soluble, indigestible oligosaccharide |
| 10/02/2008 | US20080242591 Treating vascular malformation with nicotinic acetylcholine receptor (nAChR) antagonist; arthritis, cancer |
| 10/02/2008 | US20080241961 Drosophila g protein coupled receptors, nucleic acids, and mehtods related to the same |
| 10/02/2008 | US20080241948 Mycophenolate mofetil impurity |
| 10/02/2008 | US20080241946 Kit which determines concentration of phosphate metabolizing protein and utilizes profile as indicator of hypo/hyperphosphatemic disorders |
| 10/02/2008 | US20080241873 Multi-use multimodal imaging chelates |
| 10/02/2008 | US20080241869 Microsomal Triglyceride Transfer Protein (MTP) inhibitor in combination with Liver Fatty Acid-Binding Protein (L-FABP) inhibitor; hepatits C virus; drug screening; hepatic steatosis |
| 10/02/2008 | US20080241859 Using aglycoprotein 10B antibody as diagnostic tool in detection of cell proliferative disorders associated with chronic viral diseases |
| 10/02/2008 | US20080241857 Netrin receptors |
| 10/02/2008 | US20080241835 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same |
| 10/02/2008 | US20080241817 Detection of NO By Using Guanylyl Cyclase and cGMP Production as a Readout System |
| 10/02/2008 | US20080241291 Aloe vera gel; glycolic acid, lactic acid, salicylic acid, gluconolactone exfoliants; vitamin C; vitamin A; vitamin E; buffering agent; preservative; applied to skin once or twice a day |
| 10/02/2008 | US20080241290 Sinus relief composition and method of producing the same |
| 10/02/2008 | US20080241289 Preparation and utility of non-nucleoside reverse transcriptase inhibitors |
| 10/02/2008 | US20080241284 Saw Palmetto, Sperol plant extracts by alcohol, supercritical fluid extraction; prostatic hyperplasia, prostatic cancer, hirsutism, acne, male pattern baldness, seborrhea, and other diseases related to androgen hyperactivity |
| 10/02/2008 | US20080241283 Aqueous extracts of anoectochilus spp. kinsenoside-comprising pharmaceutical compositions useful for hepatoprotection and uses of the same |
| 10/02/2008 | US20080241278 Administer amino acid precursor L-dopa, tyrosine, D,L-Phenylalanine, and N-acetyl-L-tyrosine; serotonin precursor of 5-HTP and tryptophan; and cofactors of vitamin B6, Vitamin C, Calcium, Folate, Cysteine; minimal side effects at higher doses, one precursor balances the other |
| 10/02/2008 | US20080241275 Gallium nitrate, gallium maltolate, gallium citrate, gallium phosphate, gallium chloride, gallium fluoride, gallium carbonate, gallium formate; antimicrobial agent is vancomycin, linezolid, clarithromycin, amoxicillin, metronidazole, omeprazole, bismuth subsalicylate; excludes Pseudomonas, Legionella |
| 10/02/2008 | US20080241274 Indibulin therapy |
| 10/02/2008 | US20080241265 Pharmaceutical Combinations Containing Lamivudine, Stavudine and Nevirapine |
| 10/02/2008 | US20080241263 Oral and/or Topical Compositions Comprising Prebiotics and Sterols |
| 10/02/2008 | US20080241260 Compositions for Enhanced Absorption of Biologically Active Agents |
| 10/02/2008 | US20080241257 Biodegradable Nanoparticles Incorporating Highly Hydrophilic Positively Charged Drugs |
| 10/02/2008 | US20080241255 Enhanced inhalation delivery to lungs; effective for wide range of medicants |
| 10/02/2008 | US20080241254 Having d90 value range of 4-15 mu m; bioavailable oral suspension formulations; reducing gastrointestinal tract side effects; antiprotozoal agents |
| 10/02/2008 | US20080241252 Methods and compositions for intraocular administration to treat ocular conditions |
| 10/02/2008 | US20080241251 Method of Producing Microparticles |
| 10/02/2008 | US20080241249 Cyanoacrylate composite |
| 10/02/2008 | US20080241245 Biodegradable, disposable fibrillar collagen matrix; such as bupivacaine contained in sponge; extended time postoperative pain management |
| 10/02/2008 | US20080241243 Biodegradable fibrillar collagen matrix; sustained release; postsurgery pain control |
| 10/02/2008 | US20080241241 Administering controlled release formulations utilizing slow and fast dissolving carriers; reducing side effects |
| 10/02/2008 | US20080241240 Dihydropyridine derivative delayed and statin rapid release components; preventing antagonistic and other adverse side effects; atherosclerosis, hypertension; dosage kits |
| 10/02/2008 | US20080241237 Taste-masked microparticles of hydroxyzine, cetirizine (hydrochloride), efletirizine, meclizine, buclizine or levocetirizine dihydrochloride coated with a taste-masking coating of a water insoluble polymer and an enteric polymer; orally disintegrating tablets; storage stability |
| 10/02/2008 | US20080241236 Minocycline oral dosage forms for the treatment of acne |
| 10/02/2008 | US20080241235 Controlled release carrier selected from hydroxypropyl methyl cellulose, hydroxypropyl cellulose, and polyvinylpyrrolidone; improved pharmacokinetics as compared to immediate-release minocycline hydrochloride; side effect reduction |
| 10/02/2008 | US20080241234 Preventing polymorphic conversion during preparation and storage of dosage form; ease of formulation; in vivo pharmacology; estrogen receptor modulation |
| 10/02/2008 | US20080241232 Use of green porphyrins to treat neovasculature in the eye |
| 10/02/2008 | US20080241231 Transdermal delivery of dexamethasone and promethazine |
| 10/02/2008 | US20080241227 Composition for Treating Dehydration in Large Mammals |
| 10/02/2008 | US20080241224 Non-Polymeric Lipophilic Pharmaceutical Implant Compositions For Intraocular Use |
| 10/02/2008 | US20080241223 Implanting the extended release, biodegradable implant containing dexamethasone directly into the vitreous of the eye; side effect reduction; macular degeneration; angiogenesis inhibition |
| 10/02/2008 | US20080241222 Implanting the extended release, biodegradable implant containing dexamethasone directly into the vitreous of the eye; side effect reduction; macular degeneration |
| 10/02/2008 | US20080241221 Extended therapeutic effect ocular implant treatments |
| 10/02/2008 | US20080241220 Extended therapeutic effect ocular implant treatments |